ORIC Pharamceuticals (ORIC) PT Lowered to $37 at JPMorgan
Tweet
Share
E-mailGet Alerts ORIC Hot Sheet
Price: $12.99 --0%
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 19
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 19
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on ORIC Pharamceuticals (NASDAQ: ORIC) to $37.00 (from $38.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Austal Ltd. (ASB:AU) (AUTLY) PT Raised to AUD5 at JPMorgan
- JPMorgan Downgrades Huaxia Bank Co Ltd (600015:CH) to Underweight
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
